Unregistered Sales of Equity Securities and Use of Proceeds.
−Removed: During the third quarter of
+Added: During the first quarter of
fiscal year 2026, we issued an aggregate of 170,016 restricted common shares to certain of our service providers as compensation in lieu
1 unchanged sentence
We claimed exemption from
−Removed: registration under the Securities Act, for the foregoing transactions under Section 4(a)(2) of the Securities Act.
+Added: registration under the Securities Act of 1933, as amended, or the Securities Act, for the foregoing transactions under Section 4(a)(2) of
+Added: the Securities Act.
Composite Copy of the Company’s Articles of Incorporation as amended on March 27, 2024 (incorporated by reference to Exhibit 3.3 of our quarterly report on Form 10-Q filed on May 9, 2024).
9 unchanged sentences
with the Secretary of State of the State of Nevada on March 28, 2024 (incorporated by reference to Exhibit 3.2 of our current report on Form 8-K filed on April 1, 2024).
−Removed: Share Purchase Agreement, dated March 13, 2025, between the Company, Pluri Biotech Ltd.
−Removed: and Chutzpah Holdings Limited and Plantae Bioscience (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on March 13, 2025).
−Removed: Form of Assignment and Assumption Agreement (incorporated by reference to Exhibit 10.2 of our current report on Form 8-K filed on March 13.
−Removed: Amendment to Securities Purchase Agreement, dated April 25, 2025, between the Company and Chutzpah Holdings Limited.
+Added: Amended and Restated Employment Agreement by and between Pluri Biotech Ltd.
+Added: and Liat Zalts, dated October 15, 2025.
Rule 13a-14(a) Certification of Chief Executive Officer.
4 unchanged sentences
Section 1350.
−Removed: The following materials from our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 formatted in inline XBRL (eXtensible Business Reporting Language):
+Added: The following materials from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 formatted in inline XBRL (eXtensible Business Reporting Language):
(i) the Interim Condensed Consolidated Balance Sheets, (ii) the Interim Condensed Consolidated Statements of Operations, (iii) the Interim Condensed Statements of Changes in Shareholders’ Equity, (iv) the Interim Condensed Consolidated Statements of Cash Flows, and (vi) the Notes to Interim Condensed Consolidated Financial Statements, tagged as blocks of text and in detail.
7 unchanged sentences
(Principal Executive Officer)
+Added: November 12, 2025
/s/ Liat Zalts
2 unchanged sentences
Principal Accounting Officer)
+Added: November 12, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.